Rubicon Global Announces Innovative Financing Program for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Rubicon Global Announces Innovative Financing Program for Its Hauler Network Through Partnership with The Credit Junction

ATLANTA, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Rubicon Global, the worldwide leader in sustainable, cloud-based waste and recycling solutions, is partnering with The Credit Junction to deliver flexible financing to its network of more than 5,000 haulers. Rubicon haulers will now be able to access term loans or lines of credit from $500,000 to $5 million through The Credit Junction, which offers fast, flexible and efficient business financing options. Rubicon’s technology-driven waste and recycling model empowers independent haulers to compete for customers of all sizes, operate more efficiently, and grow their businesses. In addition, the Rubicon Pro hauler membership program provides national buying power to small and medium-size businesses through industry discounts and strategic partnerships. 

“Rubicon relies on our network of independent haulers, and we’re committed to giving them the tools they need for success,” said Nate Morris, Rubicon’s co-founder and CEO. “Our partnerships with organizations like The Credit Junction help to level the playing field by enabling our haulers to grow their infrastructure and compete for business.”

The Credit Junction’s financing program includes interest-only monthly payments designed to increase the capital available as the hauler’s business and assets grow. The Credit Junction provides working capital to small and medium-size businesses, combining technology and data intelligence with traditional asset-based metrics to assess small businesses’ health more accurately.

“Rubicon Global is a company that is redefining the waste management and recycling industry through innovative technology-based solutions,” said Michael Finkelstein, The Credit Junction’s CEO & founder. “Strategic alliances like this one further The Credit Junction’s commitment to transforming the way small and mid-size businesses access their growth and working capital needs.”

To learn more about Rubicon Pro, visit https://pro.rubiconglobal.com/strategic-partners/financing/

About The Credit Junction The Credit Junction is the first data-driven asset based lending platform and is transforming the way small and mid-size businesses access working capital, growth and supply chain financing solutions. The company combines technology and data intelligence with traditional asset-based credit metrics and offers up to $5 million in capital availability. The Credit Junction targets growth-oriented suppliers, distributors and manufacturers typically with revenues between $2 and $25M. For more information, please visit:  www.thecreditjunction.com .  Twitter: @CreditJunction

About Rubicon Global Rubicon Global is the worldwide leader in sustainable, cloud-based waste and recycling solutions. Using its proprietary technology-enabled platform, the company provides comprehensive waste stream solutions that enable companies to reduce operating expenses and implement recycling programs. Rubicon’s goal is to create a more sustainable solution for businesses and the planet. Learn more at www.rubiconglobal.com .

 

Will Haraway Backbeat Marketing william@backbeatmarketing.com 404.593.8320 Sergio Rodriguera Jr. The Credit Junction sergior@thecreditjunction.com 571.278.9845

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading